196 related articles for article (PubMed ID: 33397514)
1. Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes.
Yang J; Chen T; Zhou Y
Hereditas; 2021 Jan; 158(1):4. PubMed ID: 33397514
[TBL] [Abstract][Full Text] [Related]
2. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
Li H; Xie L; Chen L; Zhang L; Han Y; Yan Z; Guo X
Aging (Albany NY); 2020 Nov; 12(22):22370-22389. PubMed ID: 33231569
[TBL] [Abstract][Full Text] [Related]
3. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
[TBL] [Abstract][Full Text] [Related]
4. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
Gkogkou E; Barnasas G; Vougas K; Trougakos IP
Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
[TBL] [Abstract][Full Text] [Related]
5. Human eggs, zygotes, and embryos express the receptor angiotensin 1-converting enzyme 2 and transmembrane serine protease 2 protein necessary for severe acute respiratory syndrome coronavirus 2 infection.
Rajput SK; Logsdon DM; Kile B; Engelhorn HJ; Goheen B; Khan S; Swain J; McCormick S; Schoolcraft WB; Yuan Y; Krisher RL
F S Sci; 2021 Feb; 2(1):33-42. PubMed ID: 33521687
[TBL] [Abstract][Full Text] [Related]
6. Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics.
Muus C; Luecken MD; Eraslan G; Sikkema L; Waghray A; Heimberg G; Kobayashi Y; Vaishnav ED; Subramanian A; Smillie C; Jagadeesh KA; Duong ET; Fiskin E; Torlai Triglia E; Ansari M; Cai P; Lin B; Buchanan J; Chen S; Shu J; Haber AL; Chung H; Montoro DT; Adams T; Aliee H; Allon SJ; Andrusivova Z; Angelidis I; Ashenberg O; Bassler K; Bécavin C; Benhar I; Bergenstråhle J; Bergenstråhle L; Bolt L; Braun E; Bui LT; Callori S; Chaffin M; Chichelnitskiy E; Chiou J; Conlon TM; Cuoco MS; Cuomo ASE; Deprez M; Duclos G; Fine D; Fischer DS; Ghazanfar S; Gillich A; Giotti B; Gould J; Guo M; Gutierrez AJ; Habermann AC; Harvey T; He P; Hou X; Hu L; Hu Y; Jaiswal A; Ji L; Jiang P; Kapellos TS; Kuo CS; Larsson L; Leney-Greene MA; Lim K; Litviňuková M; Ludwig LS; Lukassen S; Luo W; Maatz H; Madissoon E; Mamanova L; Manakongtreecheep K; Leroy S; Mayr CH; Mbano IM; McAdams AM; Nabhan AN; Nyquist SK; Penland L; Poirion OB; Poli S; Qi C; Queen R; Reichart D; Rosas I; Schupp JC; Shea CV; Shi X; Sinha R; Sit RV; Slowikowski K; Slyper M; Smith NP; Sountoulidis A; Strunz M; Sullivan TB; Sun D; Talavera-López C; Tan P; Tantivit J; Travaglini KJ; Tucker NR; Vernon KA; Wadsworth MH; Waldman J; Wang X; Xu K; Yan W; Zhao W; Ziegler CGK; ;
Nat Med; 2021 Mar; 27(3):546-559. PubMed ID: 33654293
[TBL] [Abstract][Full Text] [Related]
7. Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
D'Onofrio N; Scisciola L; Sardu C; Trotta MC; De Feo M; Maiello C; Mascolo P; De Micco F; Turriziani F; Municinò E; Monetti P; Lombardi A; Napolitano MG; Marino FZ; Ronchi A; Grimaldi V; Hermenean A; Rizzo MR; Barbieri M; Franco R; Campobasso CP; Napoli C; Municinò M; Paolisso G; Balestrieri ML; Marfella R
Cardiovasc Diabetol; 2021 May; 20(1):99. PubMed ID: 33962629
[TBL] [Abstract][Full Text] [Related]
8. ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart.
Sakamoto A; Kawakami R; Kawai K; Gianatti A; Pellegrini D; Kutys R; Guo L; Mori M; Cornelissen A; Sato Y; Bellasi A; Faggi L; Hong C; Romero M; Guagliumi G; Virmani R; Finn AV
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):542-544. PubMed ID: 33086866
[No Abstract] [Full Text] [Related]
9. Female reproductive tract has low concentration of SARS-CoV2 receptors.
Goad J; Rudolph J; Rajkovic A
PLoS One; 2020; 15(12):e0243959. PubMed ID: 33315943
[TBL] [Abstract][Full Text] [Related]
10. Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies.
Vargas-Alarcón G; Posadas-Sánchez R; Ramírez-Bello J
Life Sci; 2020 Nov; 260():118313. PubMed ID: 32835700
[TBL] [Abstract][Full Text] [Related]
11. Genomics-guided identification of potential modulators of SARS-CoV-2 entry proteases, TMPRSS2 and Cathepsins B/L.
Prasad K; AlOmar SY; Almuqri EA; Rudayni HA; Kumar V
PLoS One; 2021; 16(8):e0256141. PubMed ID: 34407143
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes.
Lu D; Chatterjee S; Xiao K; Riedel I; Wang Y; Foo R; Bär C; Thum T
J Mol Cell Cardiol; 2020 Nov; 148():46-49. PubMed ID: 32891636
[TBL] [Abstract][Full Text] [Related]
13. Genes encoding ACE2, TMPRSS2 and related proteins mediating SARS-CoV-2 viral entry are upregulated with age in human cardiomyocytes.
Robinson EL; Alkass K; Bergmann O; Maguire JJ; Roderick HL; Davenport AP
J Mol Cell Cardiol; 2020 Oct; 147():88-91. PubMed ID: 32818486
[TBL] [Abstract][Full Text] [Related]
14. ILRUN Downregulates ACE2 Expression and Blocks Infection of Human Cells by SARS-CoV-2.
Tribolet L; Alexander MR; Brice AM; van Vuren PJ; Rootes CL; Mara K; McDonald M; Bruce KL; Gough TJ; Shi S; Cowled C; Bean AGD; Stewart CR
J Virol; 2021 Jul; 95(15):e0032721. PubMed ID: 33963054
[TBL] [Abstract][Full Text] [Related]
15. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.
Kumar A; Kumar S; Narayan RK; Kumari C; Pareek V; Prasoon P
Viral Immunol; 2021 Jun; 34(5):352-357. PubMed ID: 33481684
[TBL] [Abstract][Full Text] [Related]
16. Single-cell transcriptional profile of ACE2 in healthy and failing human hearts.
Zhou Y; Huang Y; Song X; Guo X; Pang J; Wang J; Zhang S; Wang C
Sci China Life Sci; 2021 Apr; 64(4):652-655. PubMed ID: 32880862
[No Abstract] [Full Text] [Related]
17. Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19.
Katopodis P; Anikin V; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Oncol; 2020 Aug; 57(2):533-539. PubMed ID: 32468052
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
[TBL] [Abstract][Full Text] [Related]
19. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
20. Gene expression and
Aguiar JA; Tremblay BJ; Mansfield MJ; Woody O; Lobb B; Banerjee A; Chandiramohan A; Tiessen N; Cao Q; Dvorkin-Gheva A; Revill S; Miller MS; Carlsten C; Organ L; Joseph C; John A; Hanson P; Austin RC; McManus BM; Jenkins G; Mossman K; Ask K; Doxey AC; Hirota JA
Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32675206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
